{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:29:05Z","timestamp":1787851745994,"version":"build-2784847793"},"reference-count":28,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"AstraZeneca, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2026,8,24]]},"DOI":"10.1080\/10428194.2026.2687635","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:05:30Z","timestamp":1782320730000},"page":"2106-2115","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-na\u00efve CLL\/SLL"],"prefix":"10.1080","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-0533","authenticated-orcid":false,"given":"Mayur S.","family":"Narkhede","sequence":"first","affiliation":[{"name":"The University of Alabama at Birmingham","place":["Birmingham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Blau","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Peevyhouse","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Neuhalfen","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Ann","family":"Dietz","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanh","family":"Huynh","sequence":"additional","affiliation":[{"name":"Cancer Care Associates of York","place":["York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svea K.","family":"Wahlstrom","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Wilmington, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Teschemaker","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Gaithersburg, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Shetty","sequence":"additional","affiliation":[{"name":"AstraZeneca","place":["Gaithersburg, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dranitsaris","sequence":"additional","affiliation":[{"name":"ONCare Alliance","place":["Tacoma, USA"]},{"name":"Syracuse University","place":["Syracuse, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9233-294X","authenticated-orcid":false,"given":"Daniel","family":"Ermann","sequence":"additional","affiliation":[{"name":"University of Utah","place":["Salt Lake City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30422-7"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.19041"},{"key":"e_1_3_6_4_1","unstructured":"American Cancer Society. What is chronic lymphocytic leukemia (CLL)? Available from: https:\/\/www.cancer.org\/cancer\/types\/chronic-lymphocytic-leukemia\/about\/what-is-cll.html. (accessed 6 May 2025); 2025."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26367"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006434"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.4022\/jafib.467"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-013-0899-7"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2023.09.002"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018818"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05921-7"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.06.016"},{"key":"e_1_3_6_17_1","unstructured":"NCCN. Guidelines for chronic lymphocytic leukemia\/small lymphocytic lymphoma. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1478. (accessed 20 March 2026); 2026."},{"key":"e_1_3_6_18_1","unstructured":"AbbVie. IMBRUVICA\u00ae (ibrutinib) approved by U.S. FDA for the first-line treatment of chronic lymphocytic leukemia. Available from: https:\/\/news.abbvie.com\/2016-03-04-IMBRUVICA-ibrutinib-Approved-by-U-S-FDA-for-the-First-line-Treatment-of-Chronic-Lymphocytic-Leukemia. (accessed 19 March 2026); 2016."},{"key":"e_1_3_6_19_1","unstructured":"FDA. Oncology Center of Excellence 2019 Annual Report. Available from: https:\/\/www.fda.gov\/media\/134891\/download (accessed 18 June 2026). 2019."},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009739"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112011"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2023.06.003"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000840"},{"key":"e_1_3_6_25_1","volume-title":"Propensity Score Analysis: Statistical Methods and Applications","author":"Guo S","year":"2010","unstructured":"Guo S, Fraser M. Propensity Score Analysis: Statistical Methods and Applications. Vol 75. Thousand Oaks, California, USA: SAGE Publications, Inc; 2010."},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-024-01186-4"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0436"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014960"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2687635","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10428194.2026.2687635","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2026.2687635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:07:55Z","timestamp":1787850475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2026.2687635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8,24]]}},"alternative-id":["10.1080\/10428194.2026.2687635"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2026.2687635","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}